People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

110.20CHF
4:10am EDT
Price Change (% chg)

CHF-0.60 (-0.54%)
Prev Close
CHF110.80
Open
CHF111.10
Day's High
CHF111.10
Day's Low
CHF109.90
Volume
33,057
Avg. Vol
592,286
52-wk High
CHF115.50
52-wk Low
CHF59.80

Search Stocks

Fischli, Walter 

Brief Biography

Mr. Walter Fischli has been Senior Vice President Academia Relations at Actelion Ltd since July 1, 2009. He is one of the founders of the Company. He was Member of a research fellowship at Addiction Research Foundation at Stanford University. He has experience in drug discovery at F. Hoffmann-La Roche. He served as Head of Drug Discovery, Molecular Biology & Biochemistry from 1997 till June 2009. He is a Biochemist educated at Edgenoessische Technische Hochschule in Zurich (ETH) (Swiss Federal Institute of Technology, Zurich) with further training in molecular biology and organic chemistry.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks